Aspiriant LLC Sells 447 Shares of DocuSign, Inc. (NASDAQ:DOCU)

Aspiriant LLC lessened its stake in DocuSign, Inc. (NASDAQ:DOCU) by 4.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,102 shares of the company’s stock after selling 447 shares during the period. Aspiriant LLC’s holdings in DocuSign were worth $909,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the stock. Mitchell & Pahl Private Wealth LLC grew its holdings in DocuSign by 1.7% during the 4th quarter. Mitchell & Pahl Private Wealth LLC now owns 20,955 shares of the company’s stock worth $1,885,000 after acquiring an additional 345 shares during the period. Ballentine Partners LLC acquired a new position in shares of DocuSign in the 4th quarter valued at $278,000. Mitchell Mcleod Pugh & Williams Inc. acquired a new position in shares of DocuSign in the 4th quarter valued at $269,000. UMB Bank n.a. grew its holdings in shares of DocuSign by 1,654.7% in the 4th quarter. UMB Bank n.a. now owns 930 shares of the company’s stock valued at $84,000 after buying an additional 877 shares during the period. Finally, Aaron Wealth Advisors LLC grew its holdings in shares of DocuSign by 14.0% in the 4th quarter. Aaron Wealth Advisors LLC now owns 4,940 shares of the company’s stock valued at $444,000 after buying an additional 606 shares during the period. Institutional investors own 77.64% of the company’s stock.

Insider Buying and Selling

In other DocuSign news, insider Robert Chatwani sold 14,800 shares of the business’s stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $97.76, for a total value of $1,446,848.00. Following the transaction, the insider now directly owns 73,414 shares in the company, valued at $7,176,952.64. The trade was a 16.78 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Allan C. Thygesen sold 7,764 shares of the company’s stock in a transaction that occurred on Friday, November 1st. The shares were sold at an average price of $69.95, for a total transaction of $543,091.80. Following the sale, the chief executive officer now owns 107,825 shares in the company, valued at $7,542,358.75. The trade was a 6.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 693,537 shares of company stock valued at $66,575,817 over the last quarter. Insiders own 1.66% of the company’s stock.

DocuSign Stock Down 1.7 %

Shares of NASDAQ DOCU opened at $89.60 on Tuesday. DocuSign, Inc. has a twelve month low of $48.70 and a twelve month high of $107.86. The firm has a fifty day simple moving average of $88.76 and a 200 day simple moving average of $70.38. The company has a market capitalization of $18.10 billion, a PE ratio of 18.47, a P/E/G ratio of 8.10 and a beta of 0.88.

Wall Street Analyst Weigh In

Several equities research analysts have commented on DOCU shares. JMP Securities reissued a “market outperform” rating and set a $124.00 price target on shares of DocuSign in a research report on Tuesday, January 7th. Royal Bank of Canada reissued a “sector perform” rating and set a $90.00 price target (up from $57.00) on shares of DocuSign in a research report on Friday, December 6th. Morgan Stanley upped their target price on shares of DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a report on Friday, December 6th. Hsbc Global Res raised shares of DocuSign to a “moderate sell” rating in a report on Friday, December 6th. Finally, Jefferies Financial Group upped their target price on shares of DocuSign from $80.00 to $95.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, DocuSign has an average rating of “Hold” and an average price target of $92.45.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.